Charts Week Month
Heat map Market Overview
Sentiment Sectors ETFs
Earnings News Earnings Movers The Drift Pivots
The Big Picture Breakouts Full Earnings News
Investor Services

Earnings are the driver of stock prices and the right earnings information can help longer-term investors significantly outperform the overall stock market.

The Whisper Report ® A look at upcoming earnings from both a top-down and bottom-up basis. Grades Stocks with A+ Earnings Whisper Grades Have Significantly Outperformed the Stock Market. Call Summaries Conference call summaries. AI Call Analysis AI Conference call analysis. Earnings Daily earnings results. Guidance Daily earnings guidance from companies. Reactions Earnings Screener Short Interest Report When the short trade becomes crowded.
Trader Service

Short-term earnings trading tools built around expectations, sentiment, quantitative studies, volatility, and post-earnings drift.

Trading Strategy The current strategy based on a broad market analysis and data. Earnings Whisper Plays Combining research, sentiment, quantitative studies, and technical analysis for short-term trades. Scores Identifying the likely Earnings Announcement Premium. Power Ratings Earnings with enough power for a short-term Post-Earnings Announcement Drift. Whisperings ^TM Whisperings are comments from analysts about upcoming earnings releases. AI Call Rankings Find which companies had the strongest or weakest conference calls. Option Trades Volatility Options Activity Unusual options activity around earnings. Setups Unusual options activity around earnings. Reversals Unusual options activity around earnings. Spikes Unusual options activity around earnings.
Dashboard

IMDX INSIGHT MO DIAG

NASDAQ

$4.32

INSIGHT MO DIAG (IMDX) Earnings News

Earnings press releases and Earnings Whispers previews for INSIGHT MO DIAG (IMDX), newest first.

Monday August 10, 2026 4:05 PM ET

IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx

Tuesday August 4, 2026 7:00 AM ET

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Wednesday May 13, 2026 4:05 PM ET

IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization

Wednesday May 6, 2026 4:05 PM ET

iMDx to Release First Quarter 2026 Results on May 13, 2026

Thursday March 26, 2026 4:05 PM ET

IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results

Friday March 20, 2026 8:00 AM ET

iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference